Patents by Inventor Christophe Plisson

Christophe Plisson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-(2, 3, 4, 5-tetrahydro-1H-benzo [D] azepin-7-yloxy) -nicotamide derivatives as radio labelled ligands
    Patent number: 7560453
    Abstract: The present invention relates to radiolabelled compounds of formula (I), which are useful for the labelling and diagnostic imaging of histamine H3 receptor functionality.
    Type: Grant
    Filed: January 5, 2006
    Date of Patent: July 14, 2009
    Assignee: Glaxo Group Limited
    Inventor: Christophe Plisson
  • 6- (2, 3, 4, 5-Tetrahydro-1H-Benzo [D] Azepin-7-Yloxy) -Nicotamide Derivatives as Radio Labelled Ligands
    Publication number: 20080166298
    Abstract: The present invention relates to radiolabelled compounds of formula (I), which are useful for the labelling and diagnostic imaging of histamine H3 receptor functionality.
    Type: Application
    Filed: January 5, 2006
    Publication date: July 10, 2008
    Inventor: Christophe Plisson
  • Process
    Publication number: 20070059230
    Abstract: A process for preparing radiolabelled compounds by incorporation of radioactive carbonyl groups into precursors, which are then used to make the radiolabelled compounds. These radiolabelled compounds have a number of uses including in vivo imaging techniques such as positron emission tomography.
    Type: Application
    Filed: August 5, 2004
    Publication date: March 15, 2007
    Inventors: Helene Audrain, Dirk Bender, Christophe Plisson